Advertisement

Topics

Roche Diagnostics Assay Receives FDA Clearance for STD Testing

20:00 EDT 15 Apr 2018 | BioSpace

Roche said it has gained 510(k) clearance from the U.S. Food and Drug Administration for cobas CT/NG for use on the cobas 6800/8800 Systems for the detection of chlamydia and gonorrhea in both symptomatic and asymptomatic patients.

Original Article: Roche Diagnostics Assay Receives FDA Clearance for STD Testing

NEXT ARTICLE

More From BioPortfolio on "Roche Diagnostics Assay Receives FDA Clearance for STD Testing"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topic

The Top 100 Pharmaceutical Companies
Top 10 biotech and pharmaceutical companies worldwide based on market value in 2015 2015 ranking of the global top 10 biotech and pharmaceutical companies based on revenue (in billion U.S. dollars) Johnson & Johnson, U.S. 74...